{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:49:08Z","timestamp":1761094148058,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR000455"],"award-info":[{"award-number":["KL2TR000455"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.bbmt.2015.06.005","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T04:17:37Z","timestamp":1434687457000},"page":"1845-1852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases"],"prefix":"10.1016","volume":"21","author":[{"given":"Elizabeth O.","family":"Stenger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Yueh","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Haight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muna","family":"Qayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Kean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Horan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.06.005_bib1","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.06.005_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1702139","article-title":"Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet\u00a0alloimmunization","volume":"25","author":"Bellucci","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","article-title":"Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation","volume":"111","author":"Ozsahin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib5","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood-2002-02-0583","article-title":"Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000","volume":"100","author":"Seger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib6","first-page":"1195","article-title":"Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation","volume":"95","author":"Zeidler","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1542\/peds.2008-1191","article-title":"Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency","volume":"123","author":"Qasim","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2015.06.005_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.bmt.1705141","article-title":"Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry","volume":"36","author":"Donadieu","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib9","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbmt.2005.05.005","article-title":"Bone marrow transplantation for diamond-blackfan anemia","volume":"11","author":"Roy","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib10","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood-2006-07-036657","article-title":"Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia","volume":"109","author":"Wagner","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bmt.1701567","article-title":"Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation","volume":"23","author":"Ghavamzadeh","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bmt.1705600","article-title":"Hematopoietic cell transplantation for Chediak-Higashi syndrome","volume":"39","author":"Eapen","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/bmt.2008.133","article-title":"Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis","volume":"42","author":"Baker","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.2008.07030.x","article-title":"Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia","volume":"141","author":"Perez-Albuerne","year":"2008","journal-title":"Br J\u00a0Haematol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party","volume":"95","author":"Bacigalupo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.06.005_bib16","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2013-01-479733","article-title":"Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience","volume":"122","author":"Peffault de Latour","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib17","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2012.01.019","article-title":"Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)","volume":"18","author":"Kamani","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00007890-198808000-00033","article-title":"The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates","volume":"46","author":"Storb","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.06.005_bib20","first-page":"18","article-title":"The biology of graft rejection in a canine model of marrow transplantation","volume":"19","author":"Storb","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2015.06.005_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","article-title":"Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results","volume":"73","author":"Champlin","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib22","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood-2009-04-214387","article-title":"Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model","volume":"114","author":"Desmarets","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib23","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1172\/JCI39590","article-title":"Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of\u00a0bone marrow transplants in mice","volume":"119","author":"Patel","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bbmt.2015.06.005_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00007890-198612000-00001","article-title":"Failure of allogeneic canine marrow grafts after total-body irradiation. Allogeneic \u201cresistance\u201d versus transfusion-induced sensitization","volume":"42","author":"Storb","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.06.005_bib25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-6143.2005.01172.x","article-title":"NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation","volume":"6","author":"Kean","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib26","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1600-6143.2007.01864.x","article-title":"NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism","volume":"7","author":"Hamby","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib27","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/stem.1458","article-title":"The transfer of host MHC class I protein protects donor cells from NK cell and macrophage-mediated rejection during hematopoietic stem cell transplantation and engraftment in mice","volume":"31","author":"Chow","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbmt.2015.06.005_bib28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1182\/blood-2010-08-264085","article-title":"Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation","volume":"117","author":"Moretta","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2141.2011.08923.x","article-title":"Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm","volume":"156","author":"Littera","year":"2012","journal-title":"Br J\u00a0Haematol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib30","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archderm.139.12.1563","article-title":"Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts","volume":"139","author":"Gordon","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib31","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0190-9622(03)01144-7","article-title":"Combining the new biologic agents with our current psoriasis armamentarium","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib32","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.4049\/jimmunol.168.9.4462","article-title":"Alefacept, an immunomodulatory recombinant LFA-3\/IgG1 fusion protein, induces CD16 signaling and CD2\/CD16-dependent apoptosis of CD2(+) cells","volume":"168","author":"da Silva","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib33","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.4049\/jimmunol.152.6.2753","article-title":"Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure\/function analysis in\u00a0vitro and in human CD2 transgenic mice","volume":"152","author":"Majeau","year":"1994","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1022995602257","article-title":"Pharmacokinetics, biologic activity, and tolerability of alefacept by intravenous and intramuscular administration","volume":"29","author":"Vaishnaw","year":"2002","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.bbmt.2015.06.005_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00007890-199602150-00004","article-title":"Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival","volume":"61","author":"Kaplon","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.06.005_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.06.005_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-6143.2010.03317.x","article-title":"Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression","volume":"11","author":"Lo","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tmrv.2013.08.002","article-title":"Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens","volume":"27","author":"Patel","year":"2013","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.bbmt.2015.06.005_bib40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3324\/haematol.2010.027839","article-title":"Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia","volume":"96","author":"Bizzetto","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.06.005_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.2007.03380.x","article-title":"Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)\/IgG1 fusion protein alefacept","volume":"149","author":"Larsen","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib42","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1111\/ajt.12500","article-title":"Alefacept promotes immunosuppression-free renal allograft survival in nonhuman primates via depletion of recipient memory T cells","volume":"13","author":"Lee","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib43","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/ajt.12303","article-title":"Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2015.06.005_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(13)70111-6","article-title":"Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","volume":"1","author":"Rigby","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib45","doi-asserted-by":"crossref","first-page":"e47664","DOI":"10.1371\/journal.pone.0047664","article-title":"CD2 promotes human natural killer cell membrane nanotube formation","volume":"7","author":"Comerci","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.bbmt.2015.06.005_bib46","first-page":"1","article-title":"Expansion, purification, and functional assessment of human peripheral blood NK cells","volume":"48","author":"Somanchi","year":"2011","journal-title":"J\u00a0Visual Exp"},{"key":"10.1016\/j.bbmt.2015.06.005_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cellimm.2007.10.001","article-title":"Modulation of lymphocyte function with inhibitory CD2: loss of NK and NKT cells","volume":"249","author":"Ortaldo","year":"2007","journal-title":"Cell Immunol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/imr.12157","article-title":"The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)","volume":"258","author":"Foley","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2015.06.005_bib49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaad.2008.12.031","article-title":"Treatments for psoriasis and the risk of malignancy","volume":"60","author":"Patel","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib50","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1172\/JCI43895","article-title":"LFA-1-specific therapy prolongs allograft survival in rhesus macaques","volume":"120","author":"Badell","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bbmt.2015.06.005_bib51","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1182\/blood-2011-04-347252","article-title":"LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function","volume":"118","author":"Reisman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.06.005_bib52","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/TP.0b013e3181abfbf7","article-title":"Safety profile and clinical outcomes in a phase I, placebo-controlled study of siplizumab in acute graft-versus-host disease","volume":"88","author":"Adkins","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2015.06.005_bib53","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.transproceed.2009.06.226","article-title":"Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipients","volume":"41","author":"Pruett","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2015.06.005_bib54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-4632.2010.04512.x","article-title":"Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two randomized, double-blind, placebo-controlled studies","volume":"49","author":"Langley","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib55","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","article-title":"Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project","volume":"10","author":"Carson","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2015.06.005_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1741-7015-12-30","article-title":"In-\/off-label use of biologic therapy in systemic lupus erythematosus","volume":"12","author":"Gatto","year":"2014","journal-title":"BMC Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115004073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115004073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:32Z","timestamp":1761058292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115004073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1083879115004073"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.06.005","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}